Conatus Pharmaceuticals (CNAT)

6.49 +0.78 (13.66%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/2/18 *Est.)

Latest Headlines

Conatus Pharmaceuticals to Host Analyst and Investor Symposium on Portal Hypertension September 20, 2018 7:30 AM - Globe NewsWire Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences September 19, 2018 7:30 AM - Globe NewsWire Form 8-K Conatus Pharmaceuticals For: Sep 12 September 13, 2018 4:16 PM - SEC Filing Conatus Pharmaceuticals to Present at BioCentury NewsMakers Conference August 29, 2018 7:30 AM - Globe NewsWire Earnings lift European shares, banks shine August 3, 2018 3:37 AM - StreetInsider Form 10-Q Conatus Pharmaceuticals For: Jun 30 August 2, 2018 4:29 PM - SEC Filing Form 424B5 Conatus Pharmaceuticals August 2, 2018 4:19 PM - SEC Filing Form 8-K Conatus Pharmaceuticals For: Aug 01 August 1, 2018 4:08 PM - SEC Filing Conatus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Program Updates August 1, 2018 4:05 PM - Globe NewsWire Conatus Pharmaceuticals to Report Second Quarter 2018 Financial Results July 25, 2018 4:05 PM - Globe NewsWire Form SC 13G/A Conatus Pharmaceuticals Filed by: BlackRock Inc. July 10, 2018 8:27 AM - SEC Filing Conatus Pharmaceuticals’ Pan-caspase Inhibitor Emricasan Improves Survival and Portal Hypertension in a Mouse Model of Cirrhosis July 2, 2018 7:30 AM - Globe NewsWire Coming soon from Netflix: Three dozen billboards in Hollywood July 2, 2018 1:05 AM - StreetInsider Full Article List